Puma Biotechnology to present its abstract at ESMO 2017

Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.

Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389



Author :
   Editor

.



Tags

About Us

Reseapro publishes journals, provides essential resources, and facilitates a host of services. This site is intended for researchers in various domains.



Let's Talk

Do you want to learn more about how I can help your company overcome problems? Let us have a conversation.